PEAR THERAPEUTICS INC (PEAR) Stock Analyst Earnings Estimates
NASDAQ:PEAR - Nasdaq - US7047231052 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.208M | 12.694M 201.66% | 33.281M 162.18% | 69.332M 108.32% | 141.31M 103.82% | 237.89M 68.35% | 294.68M 23.87% | 366.89M 24.50% | 443.8M 20.96% | 516.22M 16.32% | ||
| EBITDA YoY % growth | N/A | -103.433M | -113.201M -9.44% | -68.055M 39.88% | -36.955M 45.70% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -2.18K | -105.685M -4,847,835.78% | -117.168M -10.87% | -76.801M 34.45% | -54.659M 28.83% | -47.678M 12.77% | 4.984M 110.45% | 16.218M 225.40% | 49.572M 205.66% | 93.228M 88.07% | 129.03M 38.40% | |
| Operating Margin | N/A | -2,511.53% | -923.02% | -230.77% | -78.84% | -33.74% | 2.10% | 5.50% | 13.51% | 21.01% | 25.00% | |
| EPS YoY % growth | N/A | N/A | N/A 78.47% | -0.46 10.00% | -0.17 62.22% | -0.20 -17.65% | 0.16 180.00% | N/A | N/A | N/A | N/A |
All data in USD
| Q1 / 23 | Q2 / 23 | Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.14 47.11% | -0.12 -406.00% | -0.10 53.64% | -0.09 43.75% | -0.07 50.00% | -0.05 58.33% | -0.04 60.00% | -0.01 88.89% |
| Revenue Q2Q % growth | 5.276M 91.92% | 5.706M 73.07% | 6.627M 62.31% | 8.143M 217.47% | 14.581M 176.36% | 16.691M 192.52% | 20.063M 202.75% | 23.591M 189.71% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -21.899M 36.97% | -21.757M 33.71% | -21.449M 16.63% | -20.834M 12.75% | -15.66M 28.49% | -15.712M 27.78% | -14.389M 32.91% | -12.994M 37.63% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 14.11% | -0.16 | % | |
| Q3 2022 Q2Q % growth | -0.22 | -0.22 | 0.00 | -0.45% |
| Q2 2022 Q2Q % growth | 0.04 | -0.25 | 0.29 | 115.94% |
| Q1 2022 Q2Q % growth | -0.27 | -0.25 | -0.02 | -9.93% |
| Q4 2021 Q2Q % growth | -0.19 | -0.42 | 0.23 | 54.63% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 2.565M -39.04% | 4.38M | -1.815M | -41.44% |
| Q3 2022 Q2Q % growth | 4.083M | 4.061M | 22K | 0.54% |
| Q2 2022 Q2Q % growth | 3.297M | 4.322M | -1.025M | -23.72% |
| Q1 2022 Q2Q % growth | 2.749M | 2.447M | 302K | 12.34% |
| Q4 2021 Q2Q % growth | 4.208M | 1.497M | 2.711M | 181.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.78% | 3.78% | 13.96% | 6.19% |
| Revenue | -12.99% | -12.99% | 0% | -0.84% |